GSK2862277: Clinical Trials

1 trial of GSK2862277, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Terminated 1

Follow GSK2862277: new trials by email Literature Review of GSK2862277 trials Research Report on GSK2862277

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of GSK2862277 in Subjects Undergoing Oesophagectomy Surgery
GSK2862277, Placebo - Lung Injury, Acute and Respiratory Distress Syndrome, Adult
Phase 2TerminatedGlaxoSmithKline352015-04-282020-10-27

Conditions studied

Lung Injury (1)  ·  Respiratory Distress Syndrome (1)

Sponsors

GlaxoSmithKline (1)

Countries

United Kingdom (1)

NIH funding

2014 (1)